# Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)

> **NCT01654861** · PHASE1 · TERMINATED · sponsor: **Eastern Regional Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Metastatic Adenocarcinoma of the Pancreas

## Interventions

- **DRUG:** Gemcitabine, Intravenous and oral Ascorbic Acid (Vitamin C)

## Key facts

- **NCT ID:** NCT01654861
- **Lead sponsor:** Eastern Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** recruiting or enrolling participants has halted prematurely and will not resume
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654861, "Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01654861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*